Hadassah

Thyroid Cancer Diagnosis Enhanced at Hadassah Using Advanced Gene Sequencing

Thursday, Aug 2 2018

left: Dr.Iddo Ben-Dov and right: Prof.Haggi Mazeh

Hadassah Medical Organization researchers, using next generation sequencing (NGS), have identified a highly accurate RNA panel that distinguishes thyroid cancer from benign nodules.

The study, authored by Prof. Haggi Mazeh, Chief of Surgery at Hadassah Hospital Mount Scopus, and Hadassah Nephrologist Dr. Iddo Ben-Dov, is highlighted in the July 26, 2018 on line issue of Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

As the authors explain, fine needle aspiration biopsy (FNAB), the gold-standard procedure for diagnosing malignant thyroid nodules, yields indeterminate cytology in 10 to 40 percent of cases. The aim of their study was to utilize NGS technology to identify diversities in the microRNA expression profile of benign versus malignant thyroid nodules. MicroRNAs are short, non-coding RNAs that regulate cell function and play a role in cancer development.

"Thyroid nodules are extremely common and occasionally harbor cancer," explains Prof. Mazeh. "Patients who undergo evaluation of thyroid nodules often receive ambiguous results, and there are currently limited options for further management, representing a clinically unmet need."

“Our panel,” the researchers concluded, “may classify indeterminate thyroid nodules with higher accuracy than commercially available molecular tests.”

Read more about this study in Medical Xpress.

Learn more about the Hadassah Medical Organization.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Monday, Oct 22 2018

Hadassah Physicians Spring Into Action to Treat Stroke Victim

Nothing could have prepared Rabbi Jonathan Halpern, 67, from suffering a stroke that quickly paralyzed his left side. Fortunately, the physicians at Hadassah Ein Kerem were totally prepared to deal with its effects and reverse the damage.

READ MORE ›
alt_text

Monday, Oct 22 2018

Hadassah Ophthalmology Department: An Environment That Encourages Insight

Throughout the past 100 years, the Hadassah Medical Organization’s Department of Ophthalmology has prioritized a platform that encourages and nurtures the development of new insights into eye diseases and the creation of new therapies, says Prof. Itay Chowers, the department’s new director.

READ MORE ›
alt_text

Thursday, Oct 18 2018

Advocacy Update | Advocate for Breast Cancer Month

At Hadassah, we're using three proven strategies to fight breast cancer: education & awareness, domestic advocacy, and support for groundbreaking research at the Hadassah Medical Organization (HMO).

READ MORE ›
alt_text

Monday, Oct 15 2018

Hadassah Dedicates Irma and Paul Milstein Heart Center at Hadassah Hospital Ein Kerem

Hadassah unveiled the Irma and Paul Milstein Heart Center at Hadassah Hospital Ein Kerem on Friday, October 12th in Jerusalem, announced Ellen Hershkin, National President, Hadassah, the Women’s Zionist Organization of America, Inc.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More